683 Capital Management »

Hyperliquid Strategies shares owned by 683 Capital Management

Quarter-by-quarter ownership of Hyperliquid Strategies (PURR) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Hyperliquid Strategies

Tip: Access up to 7 years of quarterly data

All positions including Hyperliquid Strategies held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hyperliquid Strategies by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.7M 1.6M 3.56

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Hyperliquid Strategies

D1 Capital Partners
Paradigm Operations
Galaxy Group Investments
Pantera Capital Partners
683 Capital Management
GM Advisory
Ribbit Management Company
Hrt Financial
Aristeia Capital
Jane Street
EHP Funds
Geode Capital Management
CI Private Wealth
OMERS Administration Corporation
Ikarian Capital

View all funds holding Hyperliquid Strategies